9:22 AM
Leo Group India
| ||
| Medicis Pharmaceutical's CEO Discusses Q2 2012 Results - Earnings Call ... TheStreet.com Medicis Pharmaceutical's CEO Discusses Q2 2012 Results - Earnings Call Transcript. By Seeking Alpha 08/10/12 - 06:17 PM EDT. Add Comment. Stock quotes in this article:MRX · Tweet. Medicis Pharmaceutical Corporation (MRX) ... See all stories on this topic » | ||
| Alexza Pharmaceuticals Reiterated With An Outperform At JMP Securities Seeking Alpha In a research note issued on Thursday, JMP Securities reiterated coverage with an "Outperform" rating on Alexza (ALXA), and a price target of $12.00 a share. The firm notes that Alexza ended the quarter with $26.4MM in cash, which can fund operations ... See all stories on this topic » | ||
| Medicis Pharmaceutical's CEO Discusses Q2 2012 Results - Earnings Call ... Seeking Alpha I think we have thought it more effectively than most companies out there, including the major brand named pharmaceutical companies. I think there is obviously frustration from time-to-time that we can't move as quickly as we want to. But I think we've ... See all stories on this topic » | ||
| Salix Pharmaceuticals: Hot Biotech For Long-Term Growth Seeking Alpha Salix Pharmaceuticals: Hot Biotech For Long-Term Growth. August 10, 2012 by: David Zanoni | about: SLXP. Salix Pharmaceuticals (SLXP) is a $2.66 billion large-cap compelling growth story with a vast array of gastroenterology treatments. To put it ... See all stories on this topic » | ||
| Sun Pharma to spin off local biz net up 59% Business Standard Higher sales in the US market pushed up the net profit of Sun Pharmaceutical Industries Ltd, the largest Indian drug maker by market capitalisation, by 59 per cent to Rs 796 crore in the June quarter from Rs 501 crore a year ago. Overall sales for the ... See all stories on this topic » | ||
| Salix Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript Seeking Alpha At this time, I would like to welcome everyone to Salix Pharmaceuticals' Second Quarter 2012 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. See all stories on this topic » | ||
| 6 Pharmaceutical Stocks to Buy Now Investorplace.com The grades of six Pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating. This week, Elan (NYSE:ELN) is showing significant improvement ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment